Align Technology Company Profile (NASDAQ:ALGN)

About Align Technology (NASDAQ:ALGN)

Align Technology logoAlign Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: Health Care Supplies
  • Symbol: NASDAQ:ALGN
  • CUSIP: 01625510
  • Web:
  • Market Cap: $12.74778 billion
  • Outstanding Shares: 80,331,000
Average Prices:
  • 50 Day Moving Avg: $151.84
  • 200 Day Moving Avg: $123.84
  • 52 Week Range: $82.60 - $161.81
  • Trailing P/E Ratio: 58.68
  • Foreward P/E Ratio: 39.61
  • P/E Growth: 2.06
Sales & Book Value:
  • Annual Revenue: $1.15 billion
  • Price / Sales: 10.99
  • Book Value: $13.01 per share
  • Price / Book: 12.09
  • EBIDTA: $284.34 million
  • Net Margins: 18.98%
  • Return on Equity: 22.95%
  • Return on Assets: 16.47%
  • Current Ratio: 2.51%
  • Quick Ratio: 2.42%
  • Average Volume: 1.29 million shs.
  • Beta: 1.53
  • Short Ratio: 1.47
Frequently Asked Questions for Align Technology (NASDAQ:ALGN)

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings results on Thursday, July, 27th. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.73 by $0.12. The business earned $356.50 million during the quarter, compared to analysts' expectations of $343.43 million. Align Technology had a return on equity of 22.95% and a net margin of 18.98%. The company's quarterly revenue was up 32.3% compared to the same quarter last year. During the same period last year, the firm earned $0.62 EPS. View Align Technology's Earnings History.

What guidance has Align Technology issued on next quarter's earnings?

Align Technology issued an update on its third quarter earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $0.79-0.82 for the period, compared to the Thomson Reuters consensus estimate of $0.79. The company issued revenue guidance of $355-360 million, compared to the consensus revenue estimate of $341.95 million.

Where is Align Technology's stock going? Where will Align Technology's stock price be in 2017?

7 brokers have issued 1 year target prices for Align Technology's stock. Their forecasts range from $150.00 to $200.00. On average, they expect Align Technology's share price to reach $176.71 in the next year. View Analyst Ratings for Align Technology.

What are analysts saying about Align Technology stock?

Here are some recent quotes from research analysts about Align Technology stock:

  • 1. Leerink Swann analysts commented, "healthy" (6/26/2017)
  • 2. According to Zacks Investment Research, "Ahead of its first quarter 2017 earnings, Align Technology is trading above the Zacks categorized Medical/Dental-Supplies industry for the last three months. The company’s consistently strong volumes led to top-line growth in the last reported fourth quarter 2016 earnings. Additionally, the company has a strong cash balance that enables it to adopt attractive share repurchase programs and in turn provide solid returns to investors. Going forward, management anticipates consistent growth in the Asia-Pacific region. On the flip side, currency movement continued to hurt its fourth-quarter results. The company also witnessed dull international invasilign revenue due to shipment related problem. A competitive landscape and macroeconomic headwinds continue to impact dental procedures." (4/11/2017)

Who are some of Align Technology's key competitors?

Who are Align Technology's key executives?

Align Technology's management team includes the folowing people:

  • Charles Raymond Larkin Jr., Independent Chairman of the Board
  • Joseph M. Hogan, President, Chief Executive Officer, Director
  • John F. Morici, Chief Financial Officer
  • Emory M. Wright, Vice President - Operations
  • Roger E. George, Vice President - Corporate and Legal Affairs and General Counsel
  • Simon Beard, Vice President, Managing Director - EMEA
  • Jennifer Olson, Vice President and Managing Director - Doctor Directed Consumer Channel
  • Christopher C. Puco, Vice President, Managing Director - North America
  • Julie Tay, Vice President, Managing Director - Asia Pacific
  • Stuart Hockridge, Vice President - Global Human Resources

Who owns Align Technology stock?

Align Technology's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Russell Investments Group Ltd. (0.50%), Strs Ohio (0.45%), Kornitzer Capital Management Inc. KS (0.36%), Conestoga Capital Advisors LLC (0.26%), Bank of Montreal Can (0.25%) and GW&K Investment Management LLC (0.25%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David C Nagel, David L White, Emory Wright, George J Morrow, Greg J Santora, Jennifer Erfurth, Jennifer Olson, Joseph Lacob, Julie Tay, Raphael Pascaud, Roger E George, Sreelakshmi Kolli, Thomas M Prescott, Timothy A Mack, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.

Who sold Align Technology stock? Who is selling Align Technology stock?

Align Technology's stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Rothschild Asset Management Inc., Conestoga Capital Advisors LLC, Vontobel Asset Management Inc., Kornitzer Capital Management Inc. KS, Municipal Employees Retirement System of Michigan, Oregon Public Employees Retirement Fund and Great West Life Assurance Co. Can. Company insiders that have sold Align Technology stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Jennifer Olson, Joseph Lacob, Julie Tay, Sreelakshmi Kolli, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Insider Buying and Selling for Align Technology.

Who bought Align Technology stock? Who is buying Align Technology stock?

Align Technology's stock was bought by a variety of institutional investors in the last quarter, including Chevy Chase Trust Holdings Inc., Gateway Investment Advisers LLC, Bank of Montreal Can, GW&K Investment Management LLC, Hartford Investment Management Co., Exxonmobil Investment Management Inc. TX, Mn Services Vermogensbeheer B.V. and Bedrijfstakpensioenfonds Voor DE Media PNO. View Insider Buying and Selling for Align Technology.

How do I buy Align Technology stock?

Shares of Align Technology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Align Technology's stock price today?

One share of Align Technology stock can currently be purchased for approximately $157.26.

MarketBeat Community Rating for Align Technology (NASDAQ ALGN)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  298 (Vote Outperform)
Underperform Votes:  155 (Vote Underperform)
Total Votes:  453
MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Align Technology (NASDAQ:ALGN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $176.71 (12.37% upside)

Analysts' Ratings History for Align Technology (NASDAQ:ALGN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/17/2017Morgan StanleyReiterated RatingOverweight$175.00 -> $182.00LowView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingOutperform$140.00 -> $170.00LowView Rating Details
6/26/2017Leerink SwannBoost Price TargetOutperform$149.00 -> $194.00LowView Rating Details
6/23/2017Stifel NicolausReiterated RatingMarket Perform -> Buy$145.00 -> $200.00HighView Rating Details
6/21/2017Northcoast ResearchReiterated RatingBuy$164.00 -> $186.00LowView Rating Details
6/1/2017Jefferies Group LLCReiterated RatingBuy$150.00LowView Rating Details
4/28/2017Robert W. BairdUpgradeNeutral -> Outperform$105.00 -> $155.00HighView Rating Details
5/17/2016Piper Jaffray CompaniesReiterated RatingOverweight$74.00 -> $82.00N/AView Rating Details
3/24/2016Canaccord GenuityReiterated RatingBuy$72.00 -> $80.00N/AView Rating Details
3/23/2016Roth CapitalBoost Price TargetBuy$72.00 -> $80.00N/AView Rating Details
1/29/2016William BlairReiterated RatingBuyN/AView Rating Details
1/29/2016Goldman Sachs Group, Inc. (The)Boost Price TargetBuy$67.00 -> $72.00N/AView Rating Details
(Data available from 7/28/2015 forward)


Earnings History for Align Technology (NASDAQ:ALGN)
Earnings by Quarter for Align Technology (NASDAQ:ALGN)
Earnings History by Quarter for Align Technology (NASDAQ ALGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2017Q2 2017$0.73$0.85$343.43 million$356.50 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.67$0.85$297.46 million$310.34 millionViewN/AView Earnings Details
1/31/2017Q416$0.66$0.59$292.75 million$293.20 millionViewN/AView Earnings Details
11/7/2016Q3$0.52$0.63$271.61 million$278.60 millionViewListenView Earnings Details
7/28/2016Q2$0.48$0.62$259.29 million$269.40 millionViewListenView Earnings Details
4/28/2016Q116$0.40$0.50$236.22 million$238.70 millionViewListenView Earnings Details
1/28/2016Q415$0.52$0.60$226.68 million$230.30 millionViewListenView Earnings Details
10/22/2015Q315$0.34$0.34$205.10 million$207.64 millionViewListenView Earnings Details
7/23/2015Q215$0.37$0.39$209.14 million$209.50 millionViewListenView Earnings Details
4/23/2015Q115$0.32$0.38$190.89 million$198.10 millionViewN/AView Earnings Details
1/29/2015Q414$0.49$0.48$198.10 million$198.60 millionViewN/AView Earnings Details
10/23/2014Q314$0.43$0.47$188.70 million$189.90 millionViewListenView Earnings Details
7/24/2014Q214$0.39$0.43$185.80 million$192.53 millionViewN/AView Earnings Details
4/23/2014Q114$0.35$0.39$177.57 million$180.60 millionViewN/AView Earnings Details
1/31/2014Q413$0.43$0.51$172.24 million$178.30 millionViewN/AView Earnings Details
10/17/2013Q313$0.30$0.42$158.64 million$164.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.28$0.36$156.13 million$163.80 millionViewN/AView Earnings Details
4/18/2013Q1 2013$0.23$0.26$149.40 million$153.60 millionViewN/AView Earnings Details
1/30/2013Q4 2012$0.22$0.27$134.75 million$142.80 millionViewN/AView Earnings Details
10/17/2012$0.29$0.28ViewN/AView Earnings Details
7/19/2012$0.28$0.34ViewN/AView Earnings Details
4/23/2012$0.21$0.27ViewN/AView Earnings Details
1/30/2012$0.21$0.28ViewN/AView Earnings Details
10/27/2011$0.19$0.27ViewN/AView Earnings Details
8/1/2011$0.20$0.20ViewN/AView Earnings Details
4/20/2011$0.17$0.21ViewN/AView Earnings Details
1/26/2011$0.17$0.14ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Align Technology (NASDAQ:ALGN)
2017 EPS Consensus Estimate: $3.05
2018 EPS Consensus Estimate: $3.92
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$0.65$0.70$0.67
Q2 20175$0.62$0.76$0.71
Q3 20175$0.73$0.82$0.78
Q4 20175$0.85$0.93$0.89
Q1 20184$0.80$0.89$0.84
Q2 20184$0.87$1.07$0.97
Q3 20184$0.89$1.12$1.01
Q4 20184$0.97$1.22$1.10
(Data provided by Zacks Investment Research)


Dividend History for Align Technology (NASDAQ:ALGN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Align Technology (NASDAQ:ALGN)
Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 87.93%
Insider Trades by Quarter for Align Technology (NASDAQ:ALGN)
Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)
Insider Trades by Quarter for Align Technology (NASDAQ:ALGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2017Joseph LacobDirectorSell50,000$144.98$7,249,000.00View SEC Filing  
5/30/2017Joseph LacobDirectorSell3,874$143.96$557,701.04View SEC Filing  
5/30/2017Sreelakshmi KolliVPSell1,000$144.00$144,000.00View SEC Filing  
2/28/2017Joseph LacobDirectorSell50,000$102.67$5,133,500.00View SEC Filing  
2/24/2017Christopher C PucoVPSell24,353$101.88$2,481,083.64View SEC Filing  
2/22/2017Thomas M PrescottDirectorSell66,528$101.12$6,727,311.36View SEC Filing  
2/15/2017Andrea Lynn SaiaDirectorSell4,000$99.68$398,720.00View SEC Filing  
2/3/2017C Raymond Larkin JrDirectorSell15,000$94.71$1,420,650.00View SEC Filing  
11/29/2016Jennifer OlsonVPSell3,662$95.44$349,501.28View SEC Filing  
11/29/2016Warren S ThalerDirectorSell8,500$95.57$812,345.00View SEC Filing  
11/18/2016David L WhiteCFOSell11,152$95.53$1,065,350.56View SEC Filing  
11/14/2016Thomas M PrescottDirectorSell33,125$90.60$3,001,125.00View SEC Filing  
8/29/2016Jennifer OlsonVPSell799$93.30$74,546.70View SEC Filing  
8/15/2016Zelko RelicVPSell13,577$95.91$1,302,170.07View SEC Filing  
8/9/2016Julie TayVPSell3,000$92.60$277,800.00View SEC Filing  
5/23/2016George J MorrowDirectorSell50,000$77.72$3,886,000.00View SEC Filing  
5/16/2016Raphael PascaudVPSell3,000$77.00$231,000.00View SEC Filing  
5/10/2016Julie TayVPSell1,250$77.00$96,250.00View SEC Filing  
5/5/2016C Raymond Larkin JrDirectorSell15,000$74.36$1,115,400.00View SEC Filing  
5/5/2016Roger E GeorgeVPSell27,311$75.00$2,048,325.00View SEC Filing  
5/3/2016Julie TayVPSell1,754$75.00$131,550.00View SEC Filing  
5/3/2016Thomas M PrescottDirectorSell64,773$74.54$4,828,179.42View SEC Filing  
2/25/2016Christopher C PucoVPSell11,413$63.51$724,839.63View SEC Filing  
2/23/2016Timothy A. MackVPSell28,384$63.25$1,795,288.00View SEC Filing  
2/22/2016Christopher C. PucoVPSell6,278$64.01$401,854.78View SEC Filing  
2/4/2016Greg J SantoraDirectorSell9,000$67.28$605,520.00View SEC Filing  
1/5/2016David C NagelDirectorSell1,100$64.64$71,104.00View SEC Filing  
12/14/2015David C NagelDirectorSell1,100$65.20$71,720.00View SEC Filing  
11/2/2015Julie TayVPSell1,500$66.67$100,005.00View SEC Filing  
10/30/2015Emory WrightVPSell25,272$65.04$1,643,690.88View SEC Filing  
10/28/2015Jennifer ErfurthVPSell6,198$66.04$409,315.92View SEC Filing  
10/27/2015David L. WhiteCFOSell8,426$66.85$563,278.10View SEC Filing  
10/27/2015Greg J. SantoraDirectorSell20,000$66.95$1,339,000.00View SEC Filing  
8/25/2015Andrea Lynn SaiaDirectorSell3,567$55.10$196,541.70View SEC Filing  
8/20/2015Warren S. ThalerDirectorSell7,000$58.75$411,250.00View SEC Filing  
8/17/2015Thomas M PrescottDirectorSell40,000$60.50$2,420,000.00View SEC Filing  
5/15/2015Jennifer ErfurthVPSell2,400$59.27$142,248.00View SEC Filing  
5/7/2015C Raymond Larkin JrDirectorSell15,000$59.03$885,450.00View SEC Filing  
5/6/2015Warren S ThalerDirectorSell7,000$58.75$411,250.00View SEC Filing  
5/5/2015David L WhiteCFOSell1,899$59.37$112,743.63View SEC Filing  
5/5/2015John Patrick GrahamCMOSell1,139$60.37$68,761.43View SEC Filing  
5/5/2015Timothy A MackVPSell28,280$59.47$1,681,811.60View SEC Filing  
5/1/2015Roger E GeorgeVPSell23,248$58.69$1,364,425.12View SEC Filing  
2/26/2015Raphael PascaudVPSell6,500$56.40$366,600.00View SEC Filing  
2/24/2015Christopher C PucoVPSell11,982$56.40$675,784.80View SEC Filing  
11/4/2014Timothy A MackVPSell9,375$52.17$489,093.75View SEC Filing  
10/28/2014C Raymond Larkin JrDirectorSell15,000$51.54$773,100.00View SEC Filing  
10/28/2014Jennifer ErfurthVPSell6,242$52.25$326,144.50View SEC Filing  
8/27/2014Roger E GeorgeVPSell10,875$55.85$607,368.75View SEC Filing  
8/21/2014David L WhiteCFOSell4,600$54.42$250,332.00View SEC Filing  
8/21/2014John Patrick GrahamCMOSell7,046$54.41$383,372.86View SEC Filing  
8/19/2014Thomas M PrescottCEOSell14,896$55.07$820,322.72View SEC Filing  
5/29/2014Timothy A MackVPSell16,333$55.06$899,294.98View SEC Filing  
5/1/2014Raphael PascaudVPSell2,000$50.79$101,580.00View SEC Filing  
2/25/2014Christopher PucoVPSell4,462$54.09$241,349.58View SEC Filing  
2/24/2014Roger GeorgeVPSell19,474$54.23$1,056,075.02View SEC Filing  
2/11/2014Jennifer ErfurthVPSell3,144$55.34$173,988.96View SEC Filing  
2/7/2014Thomas PrescottCEOSell236,979$54.64$12,948,532.56View SEC Filing  
2/4/2014Timothy MackVPSell12,761$54.73$698,409.53View SEC Filing  
2/4/2014Warren ThalerDirectorSell18,000$54.75$985,500.00View SEC Filing  
10/31/2013Jennifer ErfurthVPSell3,242$56.97$184,696.74View SEC Filing  
10/30/2013Richard M.L. TwomeyVPSell4,010$57.05$228,770.50View SEC Filing  
10/30/2013Thomas M PrescottCEOSell188,176$56.88$10,703,450.88View SEC Filing  
10/30/2013Warren S ThalerDirectorSell35,250$56.55$1,993,387.50View SEC Filing  
10/22/2013George J MorrowDirectorSell75,000$57.27$4,295,250.00View SEC Filing  
10/22/2013Thomas M PrescottCEOSell74,513$58.00$4,321,754.00View SEC Filing  
8/29/2013Richard M.L. TwomeyVPSell2,135$43.76$93,427.60View SEC Filing  
8/29/2013Timothy MackSVPSell18,477$43.32$800,423.64View SEC Filing  
8/9/2013Joseph LacobDirectorSell8,000$43.85$350,800.00View SEC Filing  
8/1/2013Greg SantoraDirectorSell16,000$43.79$700,640.00View SEC Filing  
7/30/2013Warren S ThalerDirectorSell10,000$42.24$422,400.00View SEC Filing  
7/25/2013Roger E GeorgeVPSell26,252$43.55$1,143,274.60View SEC Filing  
7/24/2013Richard M.L. TwomeyVPSell4,532$43.42$196,779.44View SEC Filing  
5/31/2013Joseph LacobDirectorSell49,998$36.16$1,807,927.68View SEC Filing  
5/15/2013Richard M.L. TwomeyVPSell1,875$36.10$67,687.50View SEC Filing  
2/4/2013Len HedgeSVPSell100,000$31.38$3,138,000.00View SEC Filing  
11/12/2012Dan Scott EllisVPSell18,815$26.52$498,973.80View SEC Filing  
8/9/2012Joseph LacobDirectorSell300,000$34.97$10,491,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Align Technology (NASDAQ:ALGN)
Latest Headlines for Align Technology (NASDAQ:ALGN)
DateHeadline logoAlign Technology (ALGN) Q2 2017 Results - Earnings Call Transcript - July 28 at 1:26 AM logoAlign Technology Again Makes Investors Smile With a Record Second Quarter - July 27 at 10:59 PM logoAlign Technology, Inc. (NASDAQ:ALGN) Releases Earnings Results, Beats Expectations By $0.12 EPS - July 27 at 9:42 PM logoCONMED (CNMD) Earnings Meet, Revenues Beat Estimates in Q2 - Nasdaq - July 27 at 8:22 PM logoAlign Tech posts 32% jump in sales and 38% rise in earnings; shares up 4% after hours - Seeking Alpha - July 27 at 8:22 PM logoAlign Technology Announces Record Second Quarter 2017 Results - July 27 at 8:22 PM logoAlign Technology beats Street 2Q forecasts - July 27 at 8:22 PM logoIntegra LifeSciences (IART) Q2 Earnings Meet, Revenues Miss - Nasdaq - July 27 at 3:19 PM logoMcKesson (MCK) Misses Earnings Estimates in Q1, Raises View - Nasdaq - July 27 at 3:19 PM logoMcKesson (MCK) Misses Earnings Estimates in Q1, Raises View - July 27 at 3:19 PM logoShould You Buy Align Technology (ALGN) Ahead of Earnings? - Nasdaq - July 26 at 9:02 PM logoChemed (CHE) Q2 Earnings & Revenues Rise Y/Y, View Revised - Nasdaq - July 26 at 3:55 PM logoExpress Scripts (ESRX) Earnings Top in Q2, FY17 View Up - Nasdaq - July 26 at 3:55 PM logoLabCorp (LH) Beats on Q2 Earnings and Sales, Guidance Up - Nasdaq - July 26 at 3:55 PM logo3 Stocks That Tripled in Just 3 Years - July 26 at 3:55 PM logoExpress Scripts (ESRX) Earnings Top in Q2, FY17 View Up - July 26 at 3:55 PM logoShould You Buy Align Technology (ALGN) Ahead of Earnings? - July 26 at 3:55 PM logoChemed (CHE) Q2 Earnings & Revenues Rise Y/Y, View Revised - July 26 at 3:55 PM logoMed-Products' Q2 Earnings Roster for Jul 27: ALGN, BSX & More - July 26 at 3:55 PM logoVASCO (VDSI) to Report Q2 Earnings: What's in the Offing? - July 26 at 1:34 AM logoPetMed Express (PETS) Tops Earnings, Revenue Estimates in Q1 - July 25 at 3:33 PM logo$343.25 Million in Sales Expected for Align Technology, Inc. (ALGN) This Quarter - July 21 at 3:10 PM logoAlign Technology, Inc. (ALGN) to Post FY2017 Earnings of $3.31 Per Share, Northcoast Research Forecasts - July 21 at 11:21 AM logoS&P Stealth Outperformers: Health Care - Investopedia - July 20 at 10:07 PM logoAlign Technology (ALGN) Q2 Earnings: A Beat in the Cards? - Nasdaq - July 20 at 10:07 PM logoQuest Diagnostics Closes Deal to Acquire 2 Labs in Texas - July 20 at 5:05 PM logoAlign Technology (ALGN) Q2 Earnings: A Beat in the Cards? - July 20 at 5:05 PM logoS&P Stealth Outperformers: Health Care - July 20 at 5:05 PM logoAlign Technology, Inc. (ALGN) to Release Quarterly Earnings on Thursday - July 20 at 7:07 AM logoZacks: Analysts Anticipate Align Technology, Inc. (ALGN) to Announce $0.73 EPS - July 19 at 4:04 PM logoMedtronic InterStim System Shows Five-Year Positive Results ... - Nasdaq - July 18 at 5:11 PM logoWhy Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock? - Nasdaq - July 17 at 9:09 PM logoMorgan Stanley Raises Align Technology, Inc. (NASDAQ:ALGN) Price Target to $182.00 - July 17 at 7:44 PM logoAlign Technology (ALGN): Raising Estimates - Morgan Stanley - - July 17 at 4:06 PM logoHill-Rom (HRC) at 52-Week High: What's Driving the Stock? - Nasdaq - July 17 at 4:06 PM logoCredit Suisse Group Reaffirms Outperform Rating for Align Technology, Inc. (NASDAQ:ALGN) - July 16 at 7:02 PM logoProposed Vivos Merger Could Take IMSCQ from Cents to Dollars - July 16 at 8:12 AM logoAvantor to Acquire VWR, Consolidation Promises Global Gains - Nasdaq - July 14 at 10:32 PM logoMedtronic Enrolls First Patient Under STOP AF First Trial - July 13 at 4:31 PM logoHere's Why You Should Add ResMed to Your Portfolio Now - Nasdaq - July 12 at 4:09 PM logoExpress Scripts Rides High on Increased Generic Utilization - Nasdaq - July 12 at 4:09 PM logoNeogen Introduces Test for Listeria in Environmental Samples - Nasdaq - July 11 at 5:01 PM logoMyriad Genetics to Grow with Study Successes, New Alliances - Nasdaq - July 10 at 8:40 PM logoAlign Technology Unveils New Company Logo to Unify the Invisalign and iTero Brands Under One Corporate Brand ... - Benzinga - July 10 at 8:40 PM logoMyriad Genetics to Grow with Study Successes, New Alliances - July 10 at 8:40 PM logoAlign Technology Unveils New Company Logo to Unify the Invisalign and iTero Brands Under One Corporate Brand Identity - July 10 at 8:40 PM logoInvestors Look for Gains as Abbott Labs Set to Acquire Alere - Nasdaq - July 10 at 3:38 PM logoBaxter and TAU Ink New Licensing Agreements through Ramot - July 7 at 5:59 PM logoResMed Sees Potential in SDB Market, Eyes Global Growth - July 7 at 5:59 PM logoWill Walgreens Gain from Revised Rite Aid Agreement? - Nasdaq - July 7 at 3:09 AM



Align Technology (ALGN) Chart for Friday, July, 28, 2017

This page was last updated on 7/28/2017 by Staff